Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Xtant Medical Holdings Inc (XTNT)

Xtant Medical Holdings Inc (XTNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xtant Medical Holdings Inc 664 CRUISER LANE BELGRADE MT 59714 USA

www.xtantmedical.com P: 406-388-0480

Description:

Xtant Medical Holdings, Inc. develops, manufactures and markets biologics products. The Company's product used in an applications which includes enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries. Xtant Medical Holdings, Inc., formerly known as Bacterin International Holdings, Inc., is based in Belgrade, United States.

Key Statistics

Overview:

Market Capitalization, $K 117,391
Enterprise Value, $K 133,261
Shares Outstanding, K 130,217
Annual Sales, $ 91,300 K
Annual Net Income, $ 660 K
Last Quarter Sales, $ 28,110 K
Last Quarter Net Income, $ -4,300 K
EBIT, $ -10,170 K
EBITDA, $ -7,000 K
60-Month Beta 0.22
% of Insider Shareholders 9.80%
% of Institutional Shareholders 69.33%
Float, K 117,456
% Float 90.20%
Short Volume Ratio 0.74

Growth:

1-Year Return 49.93%
3-Year Return -50.47%
5-Year Return -71.74%
5-Year Revenue Growth 26.45%
5-Year Earnings Growth 100.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.03 on 04/01/24
Latest Earnings Date 05/02/24 [--]
Earnings Per Share ttm 0.00
EPS Growth vs. Prev Qtr -142.86%
EPS Growth vs. Prev Year -50.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 02/14/18

XTNT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 1.56%
Return-on-Assets % 0.84%
Profit Margin % 0.72%
Debt/Equity 0.42
Price/Sales 1.27
Price/Cash Flow 30.85
Price/Book 2.30
Book Value/Share 0.39
Interest Coverage -0.65
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar